Next On Medicare’s To Do List For Alzheimer’s: Coverage Of PET Scans And Genetic Testing

Medicare policymakers have felt that without an effective approved treatment, coverage of amyloid PET scans and APOE4 genetic tests was not warranted. But that is changing.